A critical breakthrough in cancer study is arising with the use of mini-antibodies to re-engage dysfunctional p53. This vital cancer protector protein is frequently inactivated in various kinds of malignancies, https://getsocialselling.com/story7487934/vhh-fragments-revive-tumor-suppressor-p53-new-new-hope-for-tumor-treatment